Cesar Augusto Santa-maria MD MSCI

Dr. Cesar Santa-Maria, MD, MSCI, is an Associate Professor of Oncology at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center. He is a clinical translational researcher with nationally recognized expertise in breast cancer immunotherapy and immune biomarkers. His main research interest is in developing novel immunotherapy-based strategies and multi-platform biomarker development to identify responders to novel immune-based therapies and to understand disease biology and resistance mechanisms. Early on in his career, he received an NCI K08 grant (K08CA237863) to study breast cancer immunotherapy and has since obtained diverse funding for his research in breast cancer immunotherapy (NIH, DOD, AVON, BCRF, institutional, etc).

He has published original research and written reviews and practice algorithms on breast cancer immunotherapy. Dr. Santa-Maria conducts several investigator-initiated, collaborative group- and industry-sponsored clinical trials in breast cancer immunotherapy. He collaborates broadly with other investigators at a national level through various research consortia (TBCRC, ETCTN, NCTN) on translational research in breast cancer, where he also holds leadership positions (TBCRC Diversity Task Force Co-Chair, ETCTN Hopkins LAO Breast Co-Chair). As a nationally recognized leader in breast cancer immunotherapy, he has appointments in the NCTN Breast Immuno-oncology Task Force, NCCN Breast Cancer Panel, and Steering Committees (i.e, OPTIMICE-RD).